PolyBio

From Crisis to Cure: PolyBio is supporting top HIV researchers to pivot into the study and treatment of Long COVID. Watch the full video to learn how this collaboration is being maximized & driving forward innovative research: youtu.be/6kC1lyY6hPc?si…

Want to stay up-to-date with PolyBio’s research? Sign up for our monthly newsletter now! You’ll get access the latest news in the Infection-Associated Chronic Illness field, including interviews with PolyBio’s collaborator scientists. Next launch: early May! Sign up: polybio.org/newsletter/

2/ Read more about the infrastructure behind the Long COVID Cure Initiative, or learn how you can donate at: polybio.org/lcci/

PolyBio Long COVID Cure Initiative (LCCI) donor Steve Pagliuca has not only felt the impacts of Long COVID in his family, but also helped conceptualize the LCCI program. Said Pagliuca, “This is an opportunity to help close one of the biggest gaps in medicine today… l've seen firsthand how devastating this condition can be. Long COVID is one of the largest unmet medical challenges of our time, and the science is ready for translation. By combining philanthropic capital with a focused execution strategy, we can help compress a process that would normally take decades into just a few years.”

14/ “The biology of Long COVID is measurable. The missing piece is the infrastructure to validate those signals and translate them into biomarkers, diagnostics, and treatments,”said Todd Park, co-founder of Devoted Health and Athenahealth. “LCCI is built to deliver exactly that.”

13/ “Long COVID is one of the largest unmet medical challenges of our time, and the science is ready for translation. By combining philanthropic capital with a focused execution strategy, we can help compress a process that would normally take decades into just a few years.”

Breaking: Park-Pagliuca Fund Donates $10 Million to PolyBio Long COVID Cure Initiative PolyBio Research Foundation today announced a $10M donation to support the Long COVID Cure Initiative (LCCI), a program designed to deliver treatments to millions of Long COVID patients by translating key academic findings into real-world diagnostic tests, faster and more targeted clinical trials, and accessible, patient-ready therapies.  prnewswire.com/news-releases/…

11/ For PolyBio, the study underscores a central principle: Long COVID is not a vague syndrome but a condition with measurable biological drivers. By supporting work that identifies objective markers of disease, PolyBio is helping build the scientific foundation for the next generation of Long COVID diagnostics and targeted clinical trials. polybio.org/new-study-poly…

10/ The team proposes that a combination of microclots, neutrophil markers, endothelial cytokines, and potentially circulating Spike protein could serve as biomarkers for Long COVID – an advance that could help support more rigorous diagnosis, patient stratification, and assessment of therapeutic response in future studies.

Breaking: New PolyBio-supported Study Identifies Microclots, Endothelial Injury Markers and Neutrophil Activation in Children and Young Adults with Long COVID A new study supported by PolyBio Research Foundation studied children and young adults with Long COVID, providing evidence linking endovascular inflammation, increased quantity and size of fibrin-amyloid “microclots,” and neutrophil activation, and finding detectable Spike protein in a subset.   polybio.org/new-study-poly…